More positive news on the prospect for the different candidates getting approved and starting to be distributed.
The latest news was the FDA in the US announced that it has scheduled a meeting for December 10th to discuss the request for emergency use authorization from the Pfizer and BioNTech Vaccine. Also news of progress on the EU and UK side... So with more results of further vaccine trials expected to be announced over the coming weeks, where do we actually stand right now?
Cliona O’Farrelly, Professor of Comparative Immunology at Trinity College Dublin and Roger Highfield, Science Director at the London Science Museum both joined Susan Keogh